Pia Magnhild Helena Gideon

Président chez QLUCORE AB Fortune : 86 155 $ au 31/08/2026

Profil

Pia Magnhild Helena Gideon currently works at Qlucore AB, as Chairman from 2018, ActionAid International Sweden, as Chairman, Apoteket AB, as Director from 2017, GAIA Leadership AB, as Director, Scandi Standard AB, as Independent Director from 2022, Devyser Diagnostics AB, as Independent Director from 2021, E-Vård Mindoktor.se Sverige AB, as Director, and Gideon & Partners AB, as Director.
Ms. Gideon also formerly worked at Corem Kelly AB, as Chairman from 2016 to 2021, Simris Group AB, as Chairman from 2018 to 2019, Actionaid AB, as Chairman, Lappland Goldminers AB, as Director from 2009 to 2012, Cision AB, as Independent Director from 2010 to 2011, Semcon AB, as Director in 2008, Proact IT Group AB, as Independent Director, AgaTech ASA, as Director, Carmel Pharma AB, as Director in 2005, ScandBook AB, as Director, ScandBook Holding AB, as Director, Svevia AB, as Director, Proact IT UK Ltd., as Director, Metria AB, as Director, MD International AB, as Director, Guard Therapeutics International AB, as Independent Director from 2021 to 2023, and Wikman Gideon & Partners, as Partner.
Ms. Gideon received her graduate degree from Stockholm School of Economics.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SCANDI STANDARD AB 0,01%	12/05/2026	4 740 ( 0,01% )	71 182 $	31/08/2026
DEVYSER DIAGNOSTICS AB 0,01%	31/12/2024	2 450 ( 0,01% )	14 973 $	31/08/2026

Postes actifs de Pia Magnhild Helena Gideon

Sociétés	Poste	Début
QLUCORE AB	Président	01/01/2018
DEVYSER DIAGNOSTICS AB	Directeur/Membre du Conseil	01/01/2021
SCANDI STANDARD AB	Directeur/Membre du Conseil	04/05/2022
Gideon & Partners AB	Directeur/Membre du Conseil	-
ActionAid International Sweden	Président	-
Apoteket AB	Directeur/Membre du Conseil	01/04/2017
E-Vård Mindoktor.se Sverige AB	Directeur/Membre du Conseil	-
GAIA Leadership AB	Corporate Officer/Principal	-

Anciens postes connus de Pia Magnhild Helena Gideon

Sociétés	Poste	Fin
DISRUPTIVE PHARMA AB	Directeur/Membre du Conseil	01/05/2023
░░░░░ ░░░░░░░░ ░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░